SENSICARDIAC vs AI-ECG Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC

by Diacoustic Medical Devices (Pty) Ltd.

AI-ECG Platform

by Shenzhen Carewell Electronics Co., Ltd.

AI Verdict

SENSICARDIAC focuses on AI-powered heart murmur detection using electronic stethoscopes to classify murmurs and reduce unnecessary referrals. In contrast, the AI-ECG Platform specializes in the automatic analysis and diagnosis of 12-lead resting ECGs, identifying specific conditions like arrhythmias and myocardial infarction. While both are FDA-cleared cardiology AI tools, they address different diagnostic modalities (acoustic vs. electrical signals) and serve distinct purposes in cardiac assessment.

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your primary need is real-time, AI-powered heart murmur detection and classification using electronic stethoscopes. This tool is ideal for remote cardiac care, initial screenings, or pediatric settings where quick identification of pathological murmurs can reduce unnecessary specialist referrals and streamline the diagnostic process.

View SENSICARDIAC →

Choose AI-ECG Platform if…

Choose the AI-ECG Platform if you require rapid and highly accurate AI-driven analysis and diagnosis of 12-lead resting ECGs. This platform is best suited for cardiology clinics, emergency departments, or internal medicine practices that need to quickly interpret a broad range of cardiovascular conditions, including arrhythmias and myocardial infarction, from standard ECG data.

View AI-ECG Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC	AI-ECG Platform
Pricing	Unknown	Contact for pricing
Deployment	SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.	Workstation (with GPU), web-based portal, Windows-based diagnostic client
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC

SENSICARDIAC emphasizes a guided auscultation process, real-time analysis, and an interactive 3D patient model for remote stethoscope placement, suggesting an intuitive and supportive user experience during the examination. A validation study also indicated high usability scores from intended users.

Clinical Value

AI-ECG Platform

While both are FDA-cleared and highly accurate, the AI-ECG Platform offers a broader diagnostic range for ECGs, covering up to 45 conditions including critical ones like myocardial infarction. A significant real-world study demonstrated its AI model significantly outperformed healthcare professionals in STEMI detection, providing strong evidence of its clinical impact.

Pricing & Value

SENSICARDIAC

Both tools require direct contact for specific pricing, but SENSICARDIAC, through its integration with Telesensi, provides a general subscription price range of $25-$100 per user per month. This offers a degree of pricing transparency that Tool B lacks, while both aim to deliver value by improving diagnostic efficiency and reducing associated costs.

Enterprise Readiness

SENSICARDIAC

SENSICARDIAC explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement, which are critical for enterprise healthcare deployments. Its cloud-based architecture, white-labeling options, and dedicated integration support for telehealth platforms further demonstrate its readiness for large-scale organizational adoption.

Innovation

SENSICARDIAC

SENSICARDIAC demonstrates strong innovation by enhancing remote auscultation with live diagnostic quality stethoscope streaming and an out-of-band audio channel for superior sound quality in telehealth. Its guided auscultation process, interactive 3D patient model, and exploration of 'headless murmur detection' highlight a forward-thinking approach to cardiac care.

Support & Docs

SENSICARDIAC

SENSICARDIAC explicitly outlines its support offerings, including training for new users, demo sessions, and comprehensive integration support from telehealth experts. The availability of a detailed manual further enhances its documentation. Tool B provides no specific information regarding its support or documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC	AI-ECG Platform
Tool Name	SENSICARDIAC	AI-ECG Platform
Company	DIACOUSTIC MEDICAL (PTY)	Shenzhen Carewell Electronics Co., Ltd.
Primary Function	AI-powered heart murmur detection and classification	AI-powered automatic analysis and diagnosis system for ECG
Key Differentiator (AI Focus)	AI heart murmur screening with LIVE diagnostic quality stethoscope streaming	AI-Powered Analysis System for ECG with over 95% accuracy in diagnosing major cardiovascular diseases
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC and AI-ECG Platform.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems for seamless data transfer and reporting?

SENSICARDIAC integrates with electronic stethoscopes and generates downloadable PDF reports, fitting into the auscultation process. The AI-ECG Platform is hardware independent, compatible with most ECG machines, and supports various ECG data formats like HL7 aECG and DICOM ECG for broader integration with EHR systems.

What are the specific accuracy and sensitivity metrics for each tool in detecting the conditions they are designed for?

The AI-ECG Platform boasts over 95% accuracy in diagnosing major cardiovascular diseases, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. SENSICARDIAC classifies murmurs as pathological or physiological based on analysis against a large validated database, with reported accuracy above 95% for murmur detection, and a sensitivity of 85.6% and specificity of 84.4% for structural murmurs.

Beyond the listed specialties, what specific clinical scenarios or patient populations are each tool best suited for, given their distinct diagnostic focus?

SENSICARDIAC is ideal for primary care, internal medicine, and pediatrics for initial heart murmur screening and reducing unnecessary referrals, especially in remote care settings or for occupational physicals and athlete screenings. The AI-ECG Platform is highly beneficial in emergency medicine and cardiology for rapid, accurate interpretation of 12-lead resting ECGs to diagnose acute and chronic cardiovascular conditions like STEMI or arrhythmias.

What is the typical learning curve for physicians and clinical staff to become proficient with each system, and how quickly can a practice expect to see clinical value?

SENSICARDIAC features a guided auscultation process and real-time analysis, suggesting a relatively quick learning curve for immediate clinical utility in murmur detection. The AI-ECG Platform offers rapid diagnoses in approximately 3 seconds, indicating a fast time-to-value for efficient ECG interpretation and diagnosis, with some AI ECG platforms reporting that learning to use them took less than an hour.

How are these tools designed to support multi-site clinical rollouts, and are customer references available to demonstrate successful implementations in similar settings?

Both SENSICARDIAC, as a cloud-based service, and the AI-ECG Platform, with its web-based management portal, are inherently designed for scalability and multi-site deployment. The AI-ECG Platform has been evaluated in multi-site studies and telemedicine implementations, demonstrating feasibility for remote clinical workflows.